Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Celltrion is additionally listing 87,292 common shares on February 13, 2026, following the exercise of stock options by employees.
📊 [Key Disclosure Details & Financial Summary]
- Disclosure Title: Additional Listing (Exercise of Stock Options)
- Class and Number of Shares: 87,292 registered common shares
- 173rd Tranche: 6,838 shares
- 174th Tranche: 15,944 shares
- 175th Tranche: 18,928 shares
- 176th Tranche: 19,435 shares
- 177th Tranche: 13,664 shares
- 178th Tranche: 12,483 shares
- Issue Price per Share (Par Value: KRW 1,000):
- 173rd Tranche: KRW 79,311
- 174th Tranche: KRW 71,999
- 175th Tranche: KRW 156,285
- 176th Tranche: KRW 123,606
- 177th Tranche: KRW 156,746
- 178th Tranche: KRW 128,858
- Capital Increase Method: Exercise of stock options
- Issue Date: January 26, 2026
- Dividend Record Date: January 1, 2026
- Listing Date: February 13, 2026
- Stock Code: Standard Code KR7068270008 (Short Code A068270)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Additional Listing Execution on Scheduled Date (February 13, 2026)
This disclosure details the additional listing of 87,292 common shares resulting from the exercise of stock options, making it important to confirm the completion of the listing on the scheduled date of February 13, 2026. Tracking the share issuance ensures verification of the increase in total issued shares. Updated total share counts and capital stock changes can be verified under ‘Total Number of Shares’ and ‘Changes in Capital Stock’ in upcoming periodic filings (Quarterly, Half-Yearly, or Annual Business Reports).
📢 Disclaimer & Source Information
Source: This content was newly generated and structured based on official data submitted to the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.
Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.
Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.
